Life Planning Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$419K Hold
1,603
– – 0.33% 46
2026
Q2
$403K Hold
1,603
– – 0.3% 52
2026
Q1
$349K Hold
1,603
– – 0.27% 54
2025
Q4
$366K Hold
1,603
– – 0.28% 52
2025
Q3
$371K Hold
1,603
– – 0.27% 53
2025
Q2
$298K Hold
1,603
– – 0.24% 55
2025
Q1
$336K Hold
1,603
– – 0.3% 47
2024
Q4
$285K Hold
1,603
– – 0.26% 48
2024
Q3
$317K Hold
1,603
– – 0.28% 47
2024
Q2
$275K Hold
1,603
– – 0.25% 51
2024
Q1
$292K Buy
+1,603
New +$276K 0.29% 52

Other funds holding ABBV

Life Planning Partners's ABBV Position: Q3 2026 in Review

Life Planning Partners held its AbbVie (ABBV) position steady in Q3 2026 at 1,603 shares worth $419K. The position accounts for 0.33% of the portfolio, ranked #46.

Life Planning Partners first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Life Planning Partners held 1,603 shares of AbbVie worth $419K as of Q3 2026.
  • Life Planning Partners left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.33% of Life Planning Partners's portfolio in Q3 2026, its #46 holding.
  • Life Planning Partners first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
  • 3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Life Planning Partners's 13F filing for Q3 2026, filed 28 Oct 2026.